汇宇制药：股东黄乾益被轮候冻结28万股

Group 1 - The core point of the article is that Huyou Pharmaceutical has reported that a significant portion of its shareholder's shares has been judicially frozen, which may impact the company's stock performance and investor sentiment [1] - As of the announcement date, shareholder Huang Qianyi has approximately 21.71 million shares frozen, accounting for about 79.76% of his holdings and 5.13% of the company's total share capital [1] - The company's revenue composition for the year 2024 is heavily weighted towards pharmaceuticals, with 99.18% coming from this sector and only 0.82% from other businesses [1] Group 2 - Huyou Pharmaceutical's current market capitalization is 10.5 billion yuan [1]